Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data

This publication has 26 references indexed in Scilit:

• Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy
  Statistics in Medicine, 2004
• Mortality and progression to AIDS after starting highly active antiretroviral therapy
  AIDS, 2003
• Bayesian Measures of Model Complexity and Fit
  Journal of the Royal Statistical Society Series B: Statistical Methodology, 2002
• Factors Associated with Mortality in Human Immunodeficiency Virus Type 1–Infected Adults Initiating Protease Inhibitor–Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO–ANRS EP11 Study)
  The Journal of Infectious Diseases, 2002
• Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
  Statistics in Medicine, 2002
• Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?
  AIDS, 2002
• Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE
  HIV Medicine, 2000
• Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
  AIDS, 1999
• Predictive value of statistical models
  Statistics in Medicine, 1990
• A Defence of the Thesis THAT "THE OPPORTUNITIES OF THE GENERAL PRACTITIONER ARE ESSENTIAL FOR THE INVESTIGATION OF DISEASE AND THE PROGRESS OF MEDICINE."
  BMJ, 1921